AVBP Earnings Results and History
ArriVent BioPharma, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- Revenue–
- Net income−$49.9M
- EPS (GAAP)−$1.05
Filed Aug 12, 2026. The next earnings release shows here within a minute of filing.
EPS by quarter
GAAP diluted, 12 quartersQuarter by quarter
from 10-Q and 10-K filings| Quarter ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Jun 2026 | – | – | – | −$49.9M | −$1.05 |
| Mar 2026 | – | – | – | −$43.3M | −$0.96 |
| Dec 2025 | – | – | – | −$35.5M | −$0.78 |
| Sep 2025 | – | – | – | −$35M | −$0.83 |
EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.
Year by year
fiscal years, from 10-K filings| Year ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Dec 31, 2025 | – | – | – | −$166.3M | −$4.32 |
| Dec 31, 2024 | – | – | – | −$80.5M | −$2.56 |
| Dec 31, 2023 | – | – | – | −$69.3M | −$32.38 |
Filings and dates
SEC EDGAR- Nov 16, 2026Next earnings reportexpected
- Aug 12, 2026Quarterly report10-Q All filings
Also see AVBP institutional ownership and the earnings calendar.
AVBP earnings FAQ
When is AVBP's next earnings date?
ArriVent BioPharma, Inc. is expected to report on Nov 16, 2026. Dates can move until the company confirms them.
Is AVBP's revenue growing?
In the quarter ended Jun 30, 2026 revenue was . The table on this page shows every quarter from the company's 10-Q and 10-K filings.
Where do these numbers come from?
Results, guidance and financials come from ArriVent BioPharma, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.